1. Home
  2. Browse
  3. Practice
  4. Legal & Licensing
  5. Drug Withdrawals/Restricted Sale

Drug Withdrawals/Restricted Sale

61 - 75 of 154 Results
Sort Results:
Article: Signifor (SIG-na-for, pasireotide) is a new option for treating Cushing's disease April 2013
Article: two new cholesterol-lowering drugs, Kynamro (kye-NAM-roe, mipomersen) and Juxtapid (JUKS-tuh-pid, lomitapide) April 2013
Article: Nexafed (NEX-uh-fed) will be a new pseudoephedrine tablet designed to help curb methamphetamine production February 2013
Commentary: Nexafed (Pseudoephedrine) February 2013
Article: Patients will ask for Qsymia November 2012
Article: Combivent Respimat (ipratropium/albuterol) September 2012
Commentary: New Formulation: Combivent Respimat September 2012
Article: supplies of the direct thrombin inhibitor lepirudin (Refludan) dwindle over the next few months August 2012
Chart: Comparison of Injectable Anticoagulants August 2012
Article: You'll finally see Primatene Mist (epinephrine) disappear and the new Combivent Respimat appear November 2011
Commentary: Market Withdrawal of Primatene Mist (Epinephrine) Inhalers November 2011
Other: FDA Podcast: Withdrawal of Primatene Mist (April 2011) November 2011
Article: two new opioid formulations, Oxecta and Lazanda October 2011
Commentary: New Formulation: Oxecta (Oxycodone) October 2011
Other: Lazanda REMS Program October 2011